This piece in Science News features the MIT Jameel Clinic faculty lead for life sciences, Professor Jim Collins, and his work – at MIT Jameel Clinic for AI & Health and Phare Bio – on using AI to discover new antibiotics.

JUST ANNOUNCED: Our CEO and president, Akhila Kosaraju, will be speaking at the WIRED Health conference at Kings Place, London on March 18. Stay tuned for more leading up to the event! WIRED UK Events #WIREDHealth #Innovation #AI #AIForGood #HeathTech

COMPANY UPDATE: Our CEO and president, Akhila Kosaraju, has been invited to speak at the 11th annual LDV Capital Vision Summit on March 25. We’re excited to join some incredible leaders in #AI and #VisualTech for this exciting opportunity! 🔗Register now: ldv.co/visionsummit

🧠 Can AI transform antibiotic discovery? Join our next #REVIVE webinar, Jon Stokes & @scopekurt will explore how AI & machine learning are advancing antibiotic design, moderated by @akhilakosaraju. 📅 3 April 2025 ⏰ 17:00 – 18:30 CEST 📢 Register now:

We’re looking forward to seeing our CEO, Akhila Kosaraju, share Phare Bio’s story and hear from other incredible leaders shaping the future of health & biotech tomorrow at WIRED Health 2025! health.wired.com #WIREDHealth #Innovation #AI #AIForGood #HealthTech

Such an honor to close out #WIREDHealth today and grateful to WIRED for recognizing Phare Bio as the Startup Showcase winner -- we're incredibly energized as we chart a new AI era for antibiotics!

This week, our CEO and president, Akhila Kosaraju, will be speaking at LDV Capital’s 11th Annual LDV Vision Summit about how AI-powered drug discovery is advancing critical new classes of antibiotics to combat antimicrobial resistance. 🔗 Register now: ldv.co/visionsummit

📣 Happening tomorrow! 📣 Join our CEO @akhilakosaraju as she moderates a must-watch #REVIVE webinar Jon Stokes & @scopekurt on how AI & ML are shaping antibiotic discovery. 🗓️ April 3 | ⏰ 11AM–12:30PM ET 🔗 Register: register.gotowebinar.com/register/81374…

AI could reduce research expenses to one-third of what they might be otherwise, making it affordable to pursue antimicrobial treatments that may not have been possible with traditional methods. Akhila Kosaraju CEO of @Pharebio in @realclearhealth: realclearhealth.com/blog/2024/07/2…

We're excited to share that our CEO and President, Akhila Kosaraju, has been named to Fast Company's Impact Council, a network of forward-thinking innovators and influential business minds. ... #FastCompany #ImpactCouncil #AI #Innovation #Business #Collaboration

We're excited to share that Phare Bio has been selected by Google.org for its Generative AI Accelerator Program! This partnership will fuel our AI platform to fight antibiotic resistance and democratize life-saving drug discovery. Read more: businesswire.com/news/home/2025…

Exciting news that Phare Bio has been selected by Google.org for its Generative AI Accelerator Program! Learn more about this groundbreaking partnership and open-access, AI-powered antibiotic-discovery here: businesswire.com/news/home/2025… #Antibiotics #DrugDiscovery

Meet the 20 incredible organizations selected for the Google.org Accelerator: Generative AI! These changemakers will use #GenAI to address pressing societal challenges, from education to community resilience. Discover their inspiring work: goo.gle/3TeKDog

We’re thrilled that Phare Bio and MIT’s Collins Lab were named to Fast Company’s 2025 World Changing Ideas list! Our generative AI-powered approach to antibiotic discovery is setting a new standard in the fight against antimicrobial resistance. businesswire.com/news/home/2025…

A new initiative from Massachusetts Institute of Technology (MIT) and Phare Bio leverages generative AI to discover and develop novel antibiotics. California-based Oobli uses sweet proteins to replace sugar. In Peru, Cemento Sol invents a sidewalk to help guide the visually impaired.

Phare Bio is honored to accept Newsweek’s AI Impact Award for Most Innovative Technology or Service! Our AI-powered antibiotic discovery is helping tackle one of the world’s greatest health challenges. Thanks to Newsweek for this incredible recognition! #AIImpactAwards

“If we can reduce the number of shots on goal substantially, we can half or quarter the cost and time to get drugs to clinical trials,” says Phare Bio CEO, Dr. Akhila Kosaraju in Newsweek. Read more about our AI Impact Award win: newsweek.com/nw-ai/ai-impac…

We’re in an antibiotic crisis. Most were discovered 60+ years ago -- and resistance is rising fast. Phare Bio and the Collins Lab are using generative AI to find new ones, earning a spot on Fast Company's Company’s World Changing Ideas list. Learn more: businesswire.com/news/home/2025…

Drug-resistant infections are rising fast. Phare Bio CEO Akhila Kosaraju shares how we and the Collins Lab are using generative AI to design new antibiotics – faster and smarter. Now named to Fast Company's 2025 World Changing Ideas list. Learn more: businesswire.com/news/home/2025…

AI vs. superbugs: who wins? A new Cell study shows how #AI can design new drugs to outsmart deadly bacteria. “We’re building what we think is the most novel and robust pipeline of antibiotics in the world,” says Dr. Akhila Kosaraju, Phare Bio CEO. 🔗 spectrum.ieee.org/ai-drug-design…